Your search returned 26 results.

Sort
Results
1.
Long-term outcomes of dual vs single HER2-directed neoadjuvant therapy in NSABP B-41. MedStar authors:
  • Swain, Sandra M
PMID:
  • 36944848
Year: 2023
Citation:
  • Breast Cancer Research & Treatment. 199(2):243-252, 2023 Jun.
Department:
  • Associate Dean for Research Development
  • MedStar Health
Medline publication type:
  • Journal Article
  • Randomized Controlled Trial
Form of publication:
  • Journal Article
All authors:
  • Azar CA, Baez-Diaz L, Bandos H, Bear HD, Boileau JF, Brufsky AM, Geyer CE Jr Hassan S, Magrinat GC, Mamounas EP, Paik S, Rastogi P, Sarwar S, Shibata HR, Suga JM, Swain SM, Tang G, Wolmark N, Yothers G
2.
Risk-adapted, ofatumumab-based chemoimmunotherapy and consolidation in treatment-naive chronic lymphocytic leukemia: a phase 2 study. MedStar authors:
  • Desai, Sanjal
PMID:
  • 33653216
Year: 2021
Citation:
  • Leukemia & Lymphoma. 62(8):1816-1827, 2021 08.
Institution:
  • Washington Cancer Institute
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Ahn IE, Desai S, Drinkwater DC, Farooqui MZ, Gaglione EM, Herman SEM, Hughes TE, Lindorfer MA, Lotter J, Maric I, Marti GE, Mo C, Nichols C, Nierman P, Pleyer C, Soto S, Stetler-Stevenson M, Sun C, Superata J, Taylor RP, Tian X, Valdez J, Wake L, Wiestner A, Yuan CM
3.
Hematologic safety of palbociclib in combination with endocrine therapy in patients with benign ethnic neutropenia and advanced breast cancer. MedStar authors:
  • Blackburn, Matthew J
  • Chitalia, Ami
  • Dilawari, Asma
  • Gallagher, Christopher
  • Lynce, Filipa
  • Mohebtash, Mahsa
  • Tiwari, Shruti R
PMID:
  • 34157782
Year: 2021
Citation:
  • Cancer. 127(19):3622-3630, 2021 10 01.
Institution:
  • MedStar Franklin Square Cancer Center at Loch Raven Campus
  • MedStar Washington Hospital Center
  • Washington Cancer Institute
Department:
  • Hematology & Oncology Fellowship
  • Hematology and Oncology
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Abu-Khalaf M, Blackburn MJ, Chitalia A, Dilawari A, Gallagher C, Hahn OM, Isaacs C, Lynce F, Mohebtash M, Pohlmann PR, Shajahan-Haq AN, Tan M, Tiwari SR, Warren R, Wu T, Zhuo R
4.
HALT-D: a randomized open-label phase II study of crofelemer for the prevention of chemotherapy-induced diarrhea in patients with HER2-positive breast cancer receiving trastuzumab, pertuzumab, and a taxane. MedStar authors:
  • Kurian, Shweta
  • Mohebtash, Mahsa
  • Ottaviano, Yvonne
  • Rao, Suman
  • Swain, Sandra M
PMID:
  • 36280642
Year: 2022
Citation:
  • Breast Cancer Research & Treatment. 196(3):571-581, 2022 Dec.
Institution:
  • MedStar Franklin Square Medical Center
Department:
  • Associate Dean for Research Development
  • Hematology/Oncology
  • MedStar Health
Medline publication type:
  • Clinical Trial, Phase II
  • Journal Article
  • Randomized Controlled Trial
Form of publication:
  • Journal Article
All authors:
  • Dilawari A, Graham D, Isaacs C, Kurian S, Lynce F, Mainor C, McNamara D, Mohebtash M, Ottaviano Y, Pohlmann PR, Rao S, Swain SM, Swanson N, Tan M, Warren R, Wu T
5.
The Effect on Surgical Complications of Bevacizumab Added to Neoadjuvant Chemotherapy for Breast Cancer: NRG Oncology/NSABP Protocol B-40. MedStar authors:
  • Swain, Sandra M
PMID:
  • 27864694
Year: 2016
Citation:
  • Annals of Surgical Oncology. 24(7):1853-1860, 2017 Jul
Institution:
  • Washington Cancer Institute
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Adams PT, Baez-Diaz L, Bear HD, Brufsky AM, Costantino JP, Fehrenbacher L, Gaur R, Geyer CE Jr, Gross HM, Kidwell KM, Mamounas EP, Margolese RG, Mehta RS, Paik S, Rastogi P, Robidoux A, Senecal FM, Swain SM, Tang G, Wolmark N, Young JA, Zoon CK
6.
Phase I trial of dasatinib and ixabepilone in patients with solid tumors. MedStar authors:
  • Herbolsheimer, Pia M
  • Jelinek, James S
  • Kapoor, R
  • Perry, David J
  • Smith, Karen L
  • Swain, Sandra M
  • Verma, Nitin
  • Veytsman, Irina
PMID:
  • 22392508
Citation:
  • Investigational New Drugs. 31(1):92-8, 2013 Feb.
Institution:
  • MedStar Washington Hospital Center
  • Washington Cancer Institute
Department:
  • Radiology
Medline publication type:
  • Clinical Trial, Phase I
  • Journal Article
  • Research Support, Non-U.S. Gov't
Form of publication:
  • Journal Article
All authors:
  • Herbolsheimer P, Jelinek J, Kapoor R, Perry D, Smith KL, Swain SM, Verma N, Veytsman I
7.
Long-term Peripheral Neuropathy in Breast Cancer Patients Treated With Adjuvant Chemotherapy: NRG Oncology/NSABP B-30. MedStar authors:
  • McCarron, Edward C
  • Swain, Sandra M
PMID:
  • 28954297
Year: 2018
Citation:
  • Journal of the National Cancer Institute. 110(2), 2018 Feb 01
Institution:
  • MedStar Franklin Square Medical Center
  • Washington Cancer Institute
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Bandos H, Brufsky AM, Fehrenbacher L, Ganz PA, Julian TB, Margolese RG, McCarron EC, Melnikow J, Rivera DR, Sturtz K, Swain SM, Wade JL 3rd
8.
Treatment of older patients with HER2-positive metastatic breast cancer with pertuzumab, trastuzumab, and docetaxel: subgroup analyses from a randomized, double-blind, placebo-controlled phase III trial (CLEOPATRA). MedStar authors:
  • Swain, Sandra M
PMID:
  • 24129974
Year: 2013
Citation:
  • Breast Cancer Research & Treatment. 142(1):89-99, 2013 Nov.
Institution:
  • Washington Cancer Institute
Medline publication type:
  • Clinical Trial, Phase III
  • Journal Article
  • Multicenter Study
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't
Form of publication:
  • Journal Article
All authors:
  • Amadori D, Baselga J, Clark E, Knott A, Miles D, Ross G, Semiglazov V, Sunpaweravong P, Swain SM
9.
Pertuzumab, trastuzumab, and docetaxel in HER2-positive metastatic breast cancer. MedStar authors:
  • Swain, Sandra M
PMID:
  • 25693012
Year: 2015
Citation:
  • New England Journal of Medicine. 372(8):724-34, 2015 Feb 19.
Institution:
  • Washington Cancer Institute
Medline publication type:
  • Clinical Trial, Phase III
  • Journal Article
  • Multicenter Study
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't
Form of publication:
  • Journal Article
All authors:
  • Baselga J, Benyunes MC, Campone M, Ciruelos E, Clark E, CLEOPATRA Study Group, Cortes J, Ferrero JM, Heeson S, Kim SB, Ro J, Ross G, Schneeweiss A, Semiglazov V, Swain SM
10.
Safety profile of Pertuzumab with Trastuzumab and Docetaxel in patients from Asia with human epidermal growth factor receptor 2-positive metastatic breast cancer: results from the phase III trial CLEOPATRA. MedStar authors:
  • Swain, Sandra M
PMID:
  • 24869931
Year: 2014
Citation:
  • Oncologist. 19(7):693-701, 2014 Jul.
Institution:
  • Washington Cancer Institute
Form of publication:
  • Journal Article
All authors:
  • Baselga J, Chan V, Clark E, Im SA, Im YH, Knott A, Miles D, Ross G, Swain SM
11.
Cardiac tolerability of pertuzumab plus trastuzumab plus docetaxel in patients with HER2-positive metastatic breast cancer in CLEOPATRA: a randomized, double-blind, placebo-controlled phase III study. MedStar authors:
  • Swain, Sandra M
PMID:
  • 23475636
Year: 2013
Citation:
  • Oncologist. 18(3):257-64, 2013.
Institution:
  • Washington Cancer Institute
Medline publication type:
  • Clinical Trial, Phase III
  • Journal Article
  • Multicenter Study
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't
Form of publication:
  • Journal Article
All authors:
  • Amadori D, Baselga J, Benyunes MC, Clark E, Cortes J, Ewer MS, Knott A, Miles D, Ross G, Swain SM
12.
HALT-D: A Phase II Evaluation of Crofelemer for the Prevention and Prophylaxis of Diarrhea in Patients With Breast Cancer on Pertuzumab-Based Regimens. MedStar authors:
  • Swain, Sandra M
PMID:
  • 27692565
Year: 2017
Citation:
  • Clinical Breast Cancer. 17(1):76-78, 2017 Feb
Institution:
  • Washington Cancer Institute
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Gao JJ, Pohlmann PR, Swain SM, Tan M
13.
Report from Session III of the Second International Colloquium on Cardio-oncology: Cardio-oncological management of patients. [Review] MedStar authors:
  • Barac, Ana
PMID:
  • 31784042
Year: 2019
Citation:
  • Seminars in Oncology. 46(6):408-413, 2019 12.
Institution:
  • MedStar Heart & Vascular Institute
Medline publication type:
  • Journal Article
  • Review
Form of publication:
  • Journal Article
All authors:
  • Barac A, Cardinale DM, Khandheria BK, Lenihan D, Minotti G, Torbicki A
14.
Avastin withdrawal symptoms. MedStar authors:
  • Lynce, Filipa
  • Swain, Sandra M
PMID:
  • 22263961
Citation:
  • Expert Opinion on Pharmacotherapy. 13(3):293-8, 2012 Feb.
Institution:
  • Washington Cancer Institute
Medline publication type:
  • Editorial
  • Research Support, Non-U.S. Gov't
Form of publication:
  • Journal Article
All authors:
  • Lynce F, Swain SM
15.
A phase 1 study of lenalidomide and ibrutinib in combination with rituximab in relapsed and refractory CLL. MedStar authors:
  • Trivedi, Neel
PMID:
  • 29610115
Year: 2018
Citation:
  • Blood Advances. 2(7):762-768, 2018 Apr 10
Institution:
  • MedStar Washington Hospital Center
Department:
  • Hematology and Oncology
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Cheson BD, Khan N, Ramzi P, Skarbnik A, Trivedi N, Ujjani C, Wang H
16.
Health-related quality-of-life assessment in CLEOPATRA, a phase III study combining pertuzumab with trastuzumab and docetaxel in metastatic breast cancer. MedStar authors:
  • Swain, Sandra M
PMID:
  • 23868905
Year: 2013
Citation:
  • Annals of Oncology. 24(10):2630-5, 2013 Oct.
Institution:
  • Washington Cancer Institute
Medline publication type:
  • Clinical Trial, Phase III
  • Journal Article
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't
Form of publication:
  • Journal Article
All authors:
  • Baselga J, Clark E, Cortes J, Im SA, Im YH, Knott A, Pivot X, Ross G, Swain SM
17.
Cytoreductive surgery plus hyperthermic perioperative chemotherapy to treat peritoneal metastases from colorectal cancer: standard of care or an experimental approach?. MedStar authors:
  • Sugarbaker, Paul H
PMID:
  • 22846841
Year: 2012
Citation:
  • Lancet Oncology. 13(8):e362-9, 2012 Aug.
Institution:
  • MedStar Washington Hospital Center
Department:
  • Surgery/General Surgery
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Ryan DP, Sugarbaker PH
18.
Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA study): overall survival results from a randomised, double-blind, placebo-controlled, phase 3 study. MedStar authors:
  • Swain, Sandra M
PMID:
  • 23602601
Year: 2013
Citation:
  • Lancet Oncology. 14(6):461-71, 2013 May.
Institution:
  • Washington Cancer Institute
Medline publication type:
  • Clinical Trial, Phase III
  • Journal Article
  • Multicenter Study
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't
Form of publication:
  • Journal Article
All authors:
  • Baselga J, Benyunes MC, Campone M, Ciruelos E, Clark E, Cortes J, Ferrero JM, Kim SB, Knott A, Ro J, Ross G, Schneeweiss A, Semiglazov V, Swain SM
19.
Effect of adding mFOLFOX6 after neoadjuvant chemoradiation in locally advanced rectal cancer: a multicentre, phase 2 trial. MedStar authors:
  • Kumar, Anjali S
PMID:
  • 26187751
Citation:
  • Lancet Oncology. 16(8):957-66, 2015 Aug.
Institution:
  • MedStar Washington Hospital Center
Department:
  • Surgery/Colorectal Surgery
Medline publication type:
  • Clinical Trial, Phase II
  • Journal Article
  • Multicenter Study
  • Research Support, N.I.H., Extramural
Form of publication:
  • Journal Article
All authors:
  • Avila K, Cataldo PA, Chow OS, Coutsoftides T, Dietz DW, Fichera A, Garcia-Aguilar J, Herzig DO, Hunt SR, Kumar AS, Marcet JE, Oommen S, Patil S, Polite BN, Smith DD, Stamos MJ, Ternent CA, Timing of Rectal Cancer Response to Chemoradiation Consortium, Varma MG
20.
Long-Term Follow-Up of Cardiac Function and Quality of Life for Patients in NSABP Protocol B-31/NRG Oncology: A Randomized Trial Comparing the Safety and Efficacy of Doxorubicin and Cyclophosphamide (AC) Followed by Paclitaxel With AC Followed by Paclitaxel and Trastuzumab in Patients With Node-Positive Breast Cancer With Tumors Overexpressing Human Epidermal Growth Factor Receptor 2. MedStar authors:
  • Swain, Sandra M
  • Zapas, John L
PMID:
  • 29072977
Year: 2017
Citation:
  • Journal of Clinical Oncology. 35(35):3942-3948, 2017 Dec 10
Institution:
  • Washington Cancer Institute
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Atkins JN, Biggs DD, Brufsky AM, Cecchini RS, Fehrenbacher L, Flynn PJ, Ganz PA, Geyer CE Jr, Gross HM, Jeong JH, Mamounas EP, Polikoff J, Rastogi P, Romond EH, Seay TE, Swain SM, Wade JL 3rd, Wahl TA, Wolmark N, Zapas JL
21.
Bevacizumab added to neoadjuvant chemotherapy for breast cancer. MedStar authors:
  • Swain, Sandra M
PMID:
  • 22276821
Year: 2012
Citation:
  • New England Journal of Medicine. 366(4):310-20, 2012 Jan 26.
Institution:
  • Washington Cancer Institute
Medline publication type:
  • Journal Article
  • Multicenter Study
  • Randomized Controlled Trial
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.
Form of publication:
  • Journal Article
All authors:
  • Adams PT, Atkins JN, Baez-Diaz L, Bear HD, Brufsky AM, Costantino JP, Fehrenbacher L, Gaur R, Geyer CE Jr, Gross HM, Mamounas EP, Margolese RG, Mehta RS, Rastogi P, Robidoux A, Senecal FM, Swain SM, Tang G, Wolmark N, Young JA
22.
Trastuzumab Emtansine Plus Pertuzumab Versus Taxane Plus Trastuzumab Plus Pertuzumab After Anthracycline for High-Risk Human Epidermal Growth Factor Receptor 2-Positive Early Breast Cancer: The Phase III KAITLIN Study. MedStar authors:
  • Swain, Sandra M
PMID:
  • 34890214
Year: 2022
Citation:
  • Journal of Clinical Oncology. 40(5):438-448, 2022 02 10.
Department:
  • Associate Dean for Research Development
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Barrios C, Bonnefoi H, Boulet T, De Laurentiis M, Ellis PA, Fehrenbacher L, Gianni L, Gralow J, Harbeck N, Huang CS, Im SA, Im YH, Ito Y, Krop IE, Liu H, Macharia H, Nowecki Z, Shah J, Song C, Swain SM, Toi M, Trask P, Winer EP
23.
Health-related quality-of-life results for pembrolizumab versus chemotherapy in advanced, PD-L1-positive NSCLC (KEYNOTE-024): a multicentre, international, randomised, open-label phase 3 trial. MedStar authors:
  • Rao, Suman
PMID:
  • 29129441
Year: 2017
Citation:
  • Lancet Oncology. 18(12):1600-1609, 2017 Dec
Institution:
  • MedStar Franklin Square Hospital
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Brahmer JR, Csoszi T, Cuffe S, Deitz AC, Fulop A, Gottfried M, Hotta K, Hui R, Lubiniecki GM, O'Brien M, Peled N, Rangwala R, Rao S, Reck M, Robinson AG, Rodriguez-Abreu D, Tafreshi A, Zhang J
24.
Cardiovascular toxicity after antiangiogenic therapy in persons older than 65 years with advanced renal cell carcinoma. MedStar authors:
  • Barac, Ana
PMID:
  • 26439451
Year: 2016
Citation:
  • Cancer. 122(1):124-30, 2016 Jan 1.
Institution:
  • MedStar Heart & Vascular Institute
Medline publication type:
  • Journal Article
  • Research Support, N.I.H., Extramural
Form of publication:
  • Journal Article
All authors:
  • Atkins MB, Barac A, Freedman AN, Fu AZ, Jang S, Minasian L, Potosky AL, Tsai HT, Zheng C
25.
Lapatinib as a component of neoadjuvant therapy for HER2-positive operable breast cancer (NSABP protocol B-41): an open-label, randomised phase 3 trial. MedStar authors:
  • Swain, Sandra M
PMID:
  • 24095300
Year: 2013
Citation:
  • Lancet Oncology. 14(12):1183-92, 2013 Nov.
Institution:
  • Washington Cancer Institute
Medline publication type:
  • Clinical Trial, Phase III
  • Comparative Study
  • Journal Article
  • Multicenter Study
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't
Form of publication:
  • Journal Article
All authors:
  • Atkins JN, Azar CA, Baez-Diaz L, Bandos H, Bear HD, Brufsky AM, Costantino JP, Farrar WB, Fehrenbacher L, Geyer CE Jr, Mamounas EP, Margolese RG, Paik S, Rastogi P, Robidoux A, Sarwar S, Shibata HR, Swain SM, Tang G, Wolmark N
26.
Updated Analysis of KEYNOTE-024: Pembrolizumab Versus Platinum-Based Chemotherapy for Advanced Non-Small-Cell Lung Cancer With PD-L1 Tumor Proportion Score of 50% or Greater. MedStar authors:
  • Rao, Suman
PMID:
  • 30620668
Year: 2019
Citation:
  • Journal of Clinical Oncology. 37(7):537-546, 2019 03 01.
Institution:
  • Medstar Franklin Square Medical Center
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Brahmer JR, Csoszi T, Cuffe S, Fulop A, Gottfried M, Hotta K, Hui R, O'Brien M, Peled N, Pietanza MC, Rao S, Reck M, Riccio A, Robinson AG, Rodriguez-Abreu D, Tafreshi A, Vandormael K, Yang J
Pages

Powered by Koha